• Personalized Treatment is Better Than One Treatment Fits All in the Management of Patients with Mcrc: A Consensus Statement 

      Yalcin, Suayib; Trad, Diaeddine; Kader, Yasser Abdel; Halawani, Hafez; Demir, Osman Gokhan; Mall, Riaz; Meshcheryakov, Andrey; Nasr, Fadi; Nosworthy, Adam; Osinsky, Dmitry; Tumanova, Assel; Turhal, Serdar; Tejpar, Sabine; Koehne, Claus-Henning (Future Medicine Ltd, 2014)
      The VEGF- (bevacizumab) and EGFR- (cetuximab and panitumumab) targeting monoclonal antibodies have become integral components of the first-line treatment strategies for patients with metastatic colorectal cancer (mCRC). ...